These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 33946261)
1. Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization. Guo Y; Jin Y; Wang B; Liu B Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946261 [TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanism of Food-Derived Polyphenols on PD-L1 Dimerization: A Molecular Dynamics Simulation Study. Guo Y; Liang J; Liu B; Jin Y Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681584 [TBL] [Abstract][Full Text] [Related]
3. Is the Triggering of PD-L1 Dimerization a Potential Mechanism for Food-Derived Small Molecules in Cancer Immunotherapy? A Study by Molecular Dynamics. Wu X; Wang N; Liang J; Wang B; Jin Y; Liu B; Yang Y Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674929 [TBL] [Abstract][Full Text] [Related]
4. Computational analysis of PD-L1 dimerization mechanism induced by small molecules and potential dynamical properties. Xu X; Luo S; Zhao X; Tang B; Zhang E; Liu J; Duan L Int J Biol Macromol; 2024 Apr; 265(Pt 1):130921. PubMed ID: 38492688 [TBL] [Abstract][Full Text] [Related]
5. Approaching the Dimerization Mechanism of Small Molecule Inhibitors Targeting PD-L1 with Molecular Simulation. Liang J; Wang B; Yang Y; Liu B; Jin Y Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674800 [TBL] [Abstract][Full Text] [Related]
6. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. Guzik K; Zak KM; Grudnik P; Magiera K; Musielak B; Törner R; Skalniak L; Dömling A; Dubin G; Holak TA J Med Chem; 2017 Jul; 60(13):5857-5867. PubMed ID: 28613862 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, pharmacological evaluation, and computational study of benzo[d] isothiazol-based small molecule inhibitors targeting PD-1/PD-l1 interaction. Wang H; Shen L; Chen L; Gao Y; Ma L; Lian W; Zhang Z; Liu H; Yang H; Wang J; Zhao D; Cheng M Eur J Med Chem; 2024 Sep; 275():116622. PubMed ID: 38959727 [TBL] [Abstract][Full Text] [Related]
8. Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction. Wang Y; Kun Huang ; Gao Y; Yuan D; Ling L; Liu J; Wu S; Chen R; Li H; Xiong Y; Liu H; Ma J Eur J Med Chem; 2022 Feb; 229():113998. PubMed ID: 34839997 [TBL] [Abstract][Full Text] [Related]
9. Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction. Wu Y; Zhang Y; Guo Y; Pan Z; Zhong S; Jin X; Zhuang W; Chen S; Gao J; Huang W; Dong X; Che J Eur J Med Chem; 2021 Nov; 223():113637. PubMed ID: 34147746 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1). Zak KM; Grudnik P; Guzik K; Zieba BJ; Musielak B; Dömling A; Dubin G; Holak TA Oncotarget; 2016 May; 7(21):30323-35. PubMed ID: 27083005 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy. Zhang H; Xia Y; Yu C; Du H; Liu J; Li H; Huang S; Zhu Q; Xu Y; Zou Y Molecules; 2021 Jun; 26(11):. PubMed ID: 34199417 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive in vitro characterization of PD-L1 small molecule inhibitors. Ganesan A; Ahmed M; Okoye I; Arutyunova E; Babu D; Turnbull WL; Kundu JK; Shields J; Agopsowicz KC; Xu L; Tabana Y; Srivastava N; Zhang G; Moon TC; Belovodskiy A; Hena M; Kandadai AS; Hosseini SN; Hitt M; Walker J; Smylie M; West FG; Siraki AG; Lemieux MJ; Elahi S; Nieman JA; Tyrrell DL; Houghton M; Barakat K Sci Rep; 2019 Aug; 9(1):12392. PubMed ID: 31455818 [TBL] [Abstract][Full Text] [Related]
13. Computational Insight Into the Small Molecule Intervening PD-L1 Dimerization and the Potential Structure-Activity Relationship. Shi D; An X; Bai Q; Bing Z; Zhou S; Liu H; Yao X Front Chem; 2019; 7():764. PubMed ID: 31781546 [TBL] [Abstract][Full Text] [Related]
14. Novel Biphenyl Pyridines as Potent Small-Molecule Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Wang T; Cai S; Wang M; Zhang W; Zhang K; Chen D; Li Z; Jiang S J Med Chem; 2021 Jun; 64(11):7390-7403. PubMed ID: 34056906 [TBL] [Abstract][Full Text] [Related]
15. Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction. Sasmal P; Kumar Babasahib S; Prashantha Kumar BR; Manjunathaiah Raghavendra N Bioorg Med Chem; 2022 Nov; 73():117001. PubMed ID: 36126447 [TBL] [Abstract][Full Text] [Related]
16. Discovery of benzo[d]isothiazole derivatives as novel scaffold inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction through "ring fusion" strategy. Gao Y; Wang H; Shen L; Xu H; Deng M; Cheng M; Wang J Bioorg Chem; 2022 Jun; 123():105769. PubMed ID: 35405572 [TBL] [Abstract][Full Text] [Related]
17. Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy. Chen R; Yuan D; Ma J Future Med Chem; 2022 Jan; 14(2):97-113. PubMed ID: 34870447 [TBL] [Abstract][Full Text] [Related]
18. Investigation of protein-protein interactions and hot spot region between PD-1 and PD-L1 by fragment molecular orbital method. Lim H; Chun J; Jin X; Kim J; Yoon J; No KT Sci Rep; 2019 Nov; 9(1):16727. PubMed ID: 31723178 [TBL] [Abstract][Full Text] [Related]
19. Understanding the structural and energetic basis of PD-1 and monoclonal antibodies bound to PD-L1: A molecular modeling perspective. Shi D; Zhou S; Liu X; Zhao C; Liu H; Yao X Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):576-588. PubMed ID: 29203283 [TBL] [Abstract][Full Text] [Related]
20. From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway. Zhan MM; Hu XQ; Liu XX; Ruan BF; Xu J; Liao C Drug Discov Today; 2016 Jun; 21(6):1027-36. PubMed ID: 27094104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]